Ripretinib Versus Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumor After Treatment With Imatinib (INTRIGUE): A Randomized, Open-Label, Phase III Trial Clinical trials frequently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results